Applied BioMath

Industry-leader in applying mechanistic modeling to drug R&D, providing quantitative and predictive guidance to accelerate, optimize, and de-risk your R&D.

[Applied BioMath @AppliedBioMath]

Applied BioMath is hiring a Technical Marketing Specialist https://t.co/Xrug5laKVC via @JazzDotCo

[Applied BioMath @AppliedBioMath]

Congratulations Applied BioMath team on an insightful paper demonstrating that incorporating Early Feasibility Assessment into our discovery strategy team strategy helps all of us to achieve our goal of developing transformational…https://t.co/ghZJBkETaT https://t.co/CuIs7O2V5U

[Applied BioMath @AppliedBioMath]

Officially published in the 2023 Pi Day edition of CPTPSP. Congratulations to the Novartis and Applied BioMath teams for a great piece of sciences. https://t.co/YKXZQskIFU

[Applied BioMath @AppliedBioMath]

Top 10% of Frontiers papers! Hopefully this is inspiring a lot of teams to think about using modeling and simulation early in their drug discovery programs. Great work to the Applied BioMath Team who worked on this! https://t.co/iLJpSNPrsn

[Applied BioMath @AppliedBioMath]

Join us Thursday, September 15th, for our 5th annual QSP Summit. This is a free event that features talks from speakers at Astellas Pharma, EMD Serono Inc., Sanofi, and Xencor, as well as a poster session and networking time. Register at: https://t.co/ewUu64odem

[Genetic Engineering & Biotechnology News @GENbio]

In this GENcast we sat down with an expert in mechanistic modeling to discuss the specific of this approach and how companies are employing the technology successfully. Listen Now! — with @AppliedBioMath. Read more: https://t.co/zQU0w5jLsA

[Applied BioMath @AppliedBioMath]

Call for abstracts! Poster prizes awarded to the top three trainee (student, graduate student, and postdoc) posters. Register or submit an abstract: https://t.co/6e1HA4PjLs

[Applied BioMath @AppliedBioMath]

Dr. Alison Betts is speaking in the webinar, "Minimum Anticipated Biological Effect Level (MABEL) for Selection of First-in-Human (FIH) Starting Dose of Immune-Activating Biotherapeutics," presented by the ASCPT Oncology Community today at 1pm. Register: https://t.co/plZZaydcUY

[Applied BioMath @AppliedBioMath]

Have questions about Applied BioMath Assess™ or interested in seeing a demo? Come to our virtual office hours held every Tuesday and Thursday at 12pm ET! Register here: https://t.co/UkU59dMRE9

[BYOMass @BYOMass]

Applied BioMath Announces Collaboration with BYOMass for Systems Pharmacology Modeling in #Oncology

https://t.co/FBoy7nx14D

@AppliedBioMath #TGFβsuperfamily #biologics #smallmolecules #precisionmedicine #cancer #TGFbeta

[Applied BioMath @AppliedBioMath]

John Burke, PhD, Co-Founder, President and CEO of Applied BioMath, is presenting at Bio-IT World Conference & Expo on Tuesday, September 21th, at 10:30 a.m. ET. Learn more about his presentation at: https://t.co/YyvpreFrpo

[Applied BioMath @AppliedBioMath]

Pharma and Biotech R&D requires many incremental decisions with serious implications. We use a variety of mathematical approaches to help inform and de-risk decisions at every stage of R&D. Reach out to learn how we can support your team's decision-making! https://t.co/RQ3onvDep6

[Applied BioMath @AppliedBioMath]

Jump start your biotherapeutics and learn how Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more at: https://t.co/6JwIGFQ02k

[Applied BioMath @AppliedBioMath]

Learn how we collaborated with Alexion Pharmaceuticals to develop a QSP model which assesses a Lipid Nanoparticle to treat Crigler‐Najjar Syndrome Type 1 and to support translation from preclinical to clinical trials. View the webinar at: https://t.co/P0K6emRhe9

[Applied BioMath @AppliedBioMath]

Did you know our services span throughout the entire drug R&D continuum from discovery through clinical research? Learn more about our services and how we can help your project team at: https://t.co/kYZW4G4Nfm

[Applied BioMath @AppliedBioMath]

Learn how we collaborated with CSL Behring to develop a mathematical model for autologous stem cell therapy to cure sickle cell disease. View the publication at: https://t.co/1HbEuP2UBd

[Applied BioMath @AppliedBioMath]

We are excited to announce our collaboration with Ichnos Sciences! Check out our press release to learn how we are developing a systems pharmacology model for a bispecific antibody in oncology. Read the full press release at: https://t.co/ufT1qvvm5J

[Applied BioMath @AppliedBioMath]

Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more about our software and schedule a demo at: https://t.co/dIQ7BnDRKL

[Applied BioMath @AppliedBioMath]

Have you registered for our upcoming webinar? Tune in Thursday, April 29th, at 12pm and listen as John Burke, PhD, Co-Founder, President and CEO of Applied BioMath, explains how Applied BioMath Assess™ can help your project team. Register at: https://t.co/Lno9krQ2aS

[Applied BioMath @AppliedBioMath]

Jump start your biotherapeutics and learn how Applied BioMath Assess™ can help your project team assess the difficulties and risks in developing a therapeutic early-on in a project. Learn more at: https://t.co/A0UtOlS3DY